Contribute Try STAT+ Today

Over the past two years, many major U.S. universities have done a better job of registering clinical trials and reporting results to a federal database, a sign that demands for greater transparency are starting to have an effect on study sponsors, according to a new analysis.

Specifically, the percentage of unreported trials that were sponsored by 40 universities fell to 7% this past February from 30% in March 2019. And 17 institutions were fully compliant with reporting requirements under federal law, up from 13 two years ago. At the same time, the number of studies that were registered with more than tripled to 1,500 from nearly 450 in early 2019.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.